0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch china adalimumab industry report 2015.Your search for "" gave back 1533064 results.
The global Adalimumab Injection market size is expected to reach $ 2698.8 million by 2029, rising at a market growth of 5.4% CAGR during the forecast...
Catalog:
GIR
May 2023
Price: USD 4,480.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Biosimilar is a biologic medical product which is highly similar to another already approved biological medicine. The global Adalimumab, Infliximab...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Adalimumab Injection market was valued at US$ 1820 million in 2022 and is anticipated to reach US$ 2648.6 million by 2029, witnessing a...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Adalimumab Injection market size is projected to grow from US$ 1780.4 million in 2022 to US$ 2643.5 million in 2029; it is expected to...
Catalog:
LPI
May 2023
Price: USD 3,660.00
The global Adalimumab (Humira) and Biosimilar market size is projected to grow from US$ 21930 million in 2022 to US$ 14950 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Adalimumab Monoclonal Antibody Biosimilar market size is projected to grow from US$ 411.8 million in 2022 to US$ 966.9 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Biosimilar is a biologic medical product which is highly similar to another already approved biological medicine. Highlights The global Adalimumab,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Adalimumab Drug market will undergo major changes...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
Behcet Disease - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Behcet...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Biosimilar is a biologic medical product which is highly similar to another already approved biological medicine. The “Adalimumab, Infliximab And...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Adalimumab Monoclonal Antibody Biosimilar market size was valued at USD 433.2 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Adalimumab Injection market size was valued at USD 1872.7 million in 2022 and is forecast to a readjusted size of USD 2698.8 million by...
Catalog:
GIR
May 2023
Price: USD 3,480.00
